Low Dose Teclistamab in Newly Diagnosed Multiple Myeloma Patients

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 3, 2025

Primary Completion Date

September 7, 2026

Study Completion Date

December 1, 2026

Conditions

Multiple Myeloma, Newly Diagnosed

Interventions

DRUG

Low-dose teclistamab

NDMM patients will receive VRd 3x cicles followed by low dose teclistamab.

Trial Locations (1)

RECRUITING

Hospital Universitario Dr. Jose E. Gonzalez, Monterrey

All Listed Sponsors

lead

Hospital Universitario Dr. Jose E. Gonzalez

OTHER